Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatic pruritus].

Peter Ott1, Hendrik Vilstrup

  • 1Medicinsk Hepato-gastroenterologisk Afdeling V, Arhus Sygehus, Arhus Universitetshospital, DK-8000 Arhus C. peott@as.aaa.dk.

Ugeskrift for Laeger
|February 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A call for sharing individual patient data from trials in hepatology.

Journal of hepatology·2026
Same author

Wilson disease is a single gene disorder - comprehensive analysis of patients with prior negative genetic testing.

JHEP reports : innovation in hepatology·2026
Same author

Risk and prognosis of HCC in patients with thyroid disease: A nationwide cohort study.

Hepatology communications·2026
Same author

Primary Biliary Cholangitis Increases Mortality Irrespective of Presence or Absence of Cirrhosis.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease.

JHEP reports : innovation in hepatology·2026
Same author

Post-Translational Changes in Serum Albumin in Patients with Alcohol-Associated Hepatitis.

International journal of molecular sciences·2026
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Pruritus, a debilitating symptom of liver disease, significantly impacts patient quality of life. It is likely caused by bile acids stimulating brain opioid receptors, with treatments targeting this pathway offering relief.

Area of Science:

  • Hepatology
  • Neurogastroenterology
  • Pharmacology

Context:

  • Pruritus is a common and distressing symptom in patients with hepatic (liver) disease.
  • Severe pruritus can profoundly impair a patient's quality of life.
  • The underlying mechanisms of liver-related pruritus are not fully understood but involve specific molecular pathways.

Purpose:

  • To summarize the current understanding of pruritus in hepatic disease.
  • To outline the proposed pathophysiology involving bile acids and opioid receptors.
  • To review existing and potential therapeutic strategies for managing severe pruritus.

Summary:

  • Hepatic pruritus is strongly linked to protein-bound bile acids acting as agonists for central opioid receptors.
  • Opioid receptor antagonists, biliary diversion, and specific medications like ursodeoxycholic acid and rifampicin are established symptomatic treatments.

Related Experiment Videos

  • Advanced interventions such as plasmapheresis or albumin dialysis are considered for refractory cases.

    • Impact:

    • Provides a concise overview of liver disease-associated pruritus for clinicians and researchers.
    • Highlights the role of bile acids and opioid signaling in pruritus pathogenesis.
    • Consolidates information on diverse treatment options, guiding clinical decision-making for improved patient outcomes.